Bilastine

CAS 202189-78-4 10 current recordsSmall Molecule

Who holds supplier records for Bilastine? 10 organisations hold a current record for Bilastine: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (9) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Bilastine: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/bilastine

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Bilastine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Bilastine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Bilastine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1742423).

Chemical identity

IUPAC name
2-[4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]ethyl]phenyl]-2-methylpropanoic acid
Canonical SMILES
CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O
InChIKey
ACCMWZWAEFYUGZ-UHFFFAOYSA-N
Synonyms
Bilastina, Bilastine, Ilaxten, Bilastinum, RefChem:568338, R06AX29, Bilaxten, Bilastine [INN], Bilasten, Bilatex, Bilastine?, Bilanoa (TN)

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Bilastine?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Bilastine: METROCHEM API PRIVATE LTD (India), Viyash Scientific Ltd (India), Aurore Life Sciences (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (China), LEE PHARMA LTD (India), MALLADI DRUGS AND PHARMACEUTICALS LTD (India) and MSN LIFE SCIENCES PRIVATE LIMITED (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Bilastine Drug Master Files are active?

METROCHEM API PRIVATE LTD (DMF 36965, 43373), Viyash Scientific Ltd (DMF 38966, 40112), Aurore Life Sciences (DMF 39005), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 39332), CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (DMF 42411), LEE PHARMA LTD (DMF 36288), MALLADI DRUGS AND PHARMACEUTICALS LTD (DMF 37151) and MSN LIFE SCIENCES PRIVATE LIMITED (DMF 33720) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Bilastine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Bilastine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.